Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 4 |
| List of Tables | 8 | 1 |
| List of Figures | 9 | 1 |
| Introduction | 10 | 1 |
| Contract Manufacturing Organizations (CMO) | 11 | 5 |
| Process of CMO Outsourcing | 11 | 1 |
| Asia-Pacific CMO Market Drivers | 12 | 1 |
| Availability of Low-cost Skilled Manpower | 12 | 1 |
| Key Benefits of Outsourcing | 13 | 1 |
| Asia-Pacific CMO Market Revenues and Forecast to 2017 | 14 | 2 |
| Asia-Pacific Active Pharmaceutical Ingredients Market | 16 | 30 |
| Asia-Pacific API Industry Structure | 16 | 1 |
| Asia-Pacific API Distribution Structure | 17 | 1 |
| Asia-Pacific API Market Overview | 18 | 1 |
| Asia-Pacific APIs Market Segmentation | 19 | 1 |
| Synthetic APIs | 19 | 1 |
| Biotech APIs | 20 | 1 |
| Asia-Pacific APIs Market Drivers | 20 | 1 |
| Growing Pharmaceutical Manufacturing Capabilities of Developing Countries Such as China and India are Attracting APIs Manufacturing from Developed Countries | 20 | 1 |
| Domestic Market Growth of Developing Countries in Asia-Pacific is Providing Global Pharmaceutical Industry Growth | 20 | 1 |
| Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute Significantly to Asia-Pacific APIs Market Growth | 20 | 1 |
| The Improving Regulatory Framework in Markets of China and India is Increasing the Penetration of Branded Drugs | 21 | 1 |
| Patent Expiries of Blockbuster Drugs Boosting the Market Revenues in Asia-Pacific | 21 | 1 |
| Asia-Pacific APIs Market Restraints | 21 | 1 |
| Increasing Patent Expiries Hamper the Growth of the Branded API Market | 21 | 1 |
| Highly Fragmented Market Restricts the Revenue Growth of the Asia-Pacific API Market | 21 | 1 |
| Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential | 21 | 1 |
| High Currency Fluctuations Hamper the Value Growth of the Pharmaceutical Market in the Asia-Pacific Region | 22 | 1 |
| Asia-Pacific APIs Market Revenue and Forecasts to 2017 | 22 | 2 |
| Asia-Pacific Revenue Share Analysis by Product Types | 24 | 1 |
| Asia-Pacific Synthetic APIs Market | 25 | 1 |
| Asia-Pacific Synthetic APIs Market Drivers | 25 | 1 |
| Increasing Penetration and Domestic Growth in Developing Countries will Boost the Growth of the Synthetic API Market | 25 | 1 |
| Healthy Growth in Generic Sectors Drives the Overall Growth of the Synthetic API Market in Asia-Pacific | 25 | 1 |
| Asia-Pacific Synthetic APIs Market Restraints | 25 | 1 |
| Highly Fragmented API Market May Hamper Industry Growth by Reducing Profitability | 25 | 1 |
| Slow Growth in the Almost Matured Market of Japan May Limit the Regional Growth | 25 | 1 |
| Patent Expiries of Branded Drugs are Slowing the Innovative APIs Market Growth and Reducing Overall Growth of the Synthetic APIs Market in the Region | 26 | 1 |
| Asia-Pacific Synthetic Market Revenues and Forecast to 2017 | 26 | 2 |
| Asia-Pacific Synthetic Market Revenue Share Analysis by Countries | 28 | 2 |
| Asia-Pacific Revenue Share Analysis by Countries | 30 | 1 |
| Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base | 31 | 1 |
| Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 | 32 | 2 |
| Asia-Pacific Biotech APIs Market | 34 | 1 |
| Asia-Pacific Biotech APIs Market Drivers | 34 | 1 |
| Increasing Uptake of Biopharmaceuticals or Specialty Drugs Across Different Therapeutic Areas | 34 | 1 |
| Increasing Biologics Clusters | 34 | 1 |
| Asia-Pacific Biotech APIs Market Restraints | 34 | 1 |
| Complex Manufacturing Procedures for Biopharmaceuticals | 34 | 1 |
| Research Collaboration Required | 34 | 1 |
| Complex Cost Structures in Outsourcing | 34 | 1 |
| Asia-Pacific Biotech Market Revenues and Forecasts to 2017 | 35 | 2 |
| Asia-Pacific Biotech Market Revenue Share Analysis by Countries | 37 | 2 |
| Asia-Pacific Biotech Revenue Share Analysis by Countries | 39 | 1 |
| Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base | 40 | 1 |
| Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 | 41 | 2 |
| Asia-Pacific Patent Expiry of Leading Biologics | 43 | 1 |
| Asia-Pacific APIs Market Share Analysis by Therapeutic Applications | 44 | 2 |
| Japan Active Pharmaceutical Ingredients Market | 46 | 10 |
| Japan APIs Market Overview | 46 | 1 |
| Japan APIs Market Revenue and Forecasts to 2017 | 46 | 2 |
| Japan APIs Market Revenue Share Analysis by Product Type | 48 | 1 |
| Japan APIs Market by Customer Base | 49 | 1 |
| Japan Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 49 | 2 |
| Japan Synthetic Market Revenue Share Analysis by Customer Base | 51 | 1 |
| Japan Biotech Market Revenue by Customer Base and Forecasts to 2017 | 52 | 2 |
| Japan Biotech Market Revenue Share Analysis by Customer Base | 54 | 1 |
| Japan APIs Market Share Analysis by Therapeutic Applications | 55 | 1 |
| China Active Pharmaceutical Ingredients Market | 56 | 12 |
| China APIs Market Overview | 56 | 1 |
| China API Market Revenues by Product Type and Forecasts to 2017 | 56 | 3 |
| China APIs Market Revenue Share Analysis by Product Types | 59 | 1 |
| China APIs Market by Customer Base | 60 | 1 |
| China Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 60 | 2 |
| China Synthetic Market Revenue Share Analysis by Customer Base | 62 | 1 |
| China Biotech Market Revenue by Customer Base and Forecast to 2017 | 63 | 2 |
| China Biotech Market Revenue Share Analysis by Customer Base | 65 | 1 |
| China APIs Market Share Analysis by Therapeutic Applications | 66 | 2 |
| South Korea Active Pharmaceutical Ingredients Market | 68 | 13 |
| South Korea APIs Market Overview | 68 | 1 |
| South Korea APIs Market Revenue and Forecasts to 2017 | 68 | 3 |
| South Korea APIs Market Revenue Share Analysis by Product Type | 71 | 1 |
| South Korea APIs Market by Customer Base | 72 | 1 |
| South Korea Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 72 | 3 |
| South Korea Synthetic Market Revenue Share Analysis by Customer Base | 75 | 1 |
| South Korea Biotech Market Revenue by Customer Base and Forecasts to 2017 | 76 | 2 |
| South Korea Biotech Market Revenue Share Analysis by Customer Base | 78 | 1 |
| South Korea APIs Market Share Analysis by Therapeutic Applications | 79 | 2 |
| India Active Pharmaceutical Ingredients Market | 81 | 12 |
| India APIs Market Overview | 81 | 1 |
| India APIs Market Revenue and Forecasts to 2017 | 81 | 3 |
| India APIs Market Revenue Share Analysis by Product Types | 84 | 1 |
| India APIs Market by Customer Base | 85 | 1 |
| India Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 85 | 2 |
| India Synthetic Market Revenue Share Analysis by Customer Base | 87 | 1 |
| India Biotech Market Revenue by Customer Base and Forecasts to 2017 | 88 | 2 |
| India Biotech Market Revenue Share Analysis by Customer Base | 90 | 1 |
| India APIs Market Revenue Analysis by Therapeutic Applications | 91 | 2 |
| Appendix | 93 | 3 |
| Abbreviations | 93 | 1 |
| Bibliography | 93 | 1 |
| Market Definitions | 94 | 1 |
| Methodology | 94 | 2 |
| Coverage | 94 | 1 |
| Secondary Research | 94 | 1 |
| Primary Research | 95 | 1 |
| Expert Panel Validation | 95 | 1 |
| Contact Us | 95 | 1 |
| Disclaimer | 95 | 1 |
